Ipsen’s Iqirvo Secures FDA Accelerated Approval For Primary Biliary Cholangitis Treatment

view original post

The U.S. Food and Drug Administration has granted accelerated approval for Iqirvo (elafibranor) 80 mg tablets for the treatment of primary biliary cholangitis or PBC in combination with …